Lyra presented the positive ENLIGHTEN 2 Phase 3 results as a Late-Breaking Scientific Oral Presentation at the Annual Meeting of the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) ...
Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis: Paris Monday, November 10, ...
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...
Congestion - that bunged up, stuffy nose feeling - is usually a fleeting symptom of a cold which lasts for around a week and ...
The national consumer disputes redressal commission (NCDRC) has upheld the Rajasthan state consumer commission’s finding of ...
GlobalData on MSN
Dupixent set for ninth US approval after Phase III AFRS success
Sanofi and Regeneron’s Dupixent (dupilumab) could be set for its ninth US approval after the drug met all the primary and secondary endpoints in a Phase III study in allergic fungal rhinosinusitis ...
Have you been having headaches that won't go away, confusion or changes in your senses? You may wonder if these are signs of ...
Ethan Monck's life is divided into three parts. His first two years, which were marked by a double cancer diagnosis; the nine ...
Nasal irrigation has been used to treat the common cold for thousands of years, and modern science shows that it works.
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily ...
Michael Jackson’s daughter recently took to TikTok to reveal the issue that’s still plaguing her years later, warning viewers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback